Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of Literature
Psoriasis and type 1 diabetes mellitus (T1DM) are chronic autoimmune diseases sharing common immunological pathways, particularly the involvement of interleukin 17 (IL-17), driving Th17-mediated inflammation. This review explores the overlap between psoriasis, obesity, T1DM, and necrobiosis lipoidic...
Saved in:
| Main Authors: | Angelika Bielach-Bazyluk, Filip Bossowski, Magdalena Skorupska, Hanna Mysliwiec, Artur Tadeusz Bossowski, Iwona Flisiak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/8/610 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Association Between Psoriasis and Metabolic Syndrome in Children: A Narrative Review
by: Mateusz Matwiejuk, et al.
Published: (2025-06-01) -
Brodalumab for Moderate-to-Severe Psoriasis: A Comprehensive Review of Efficacy, Safety, and Clinical Positioning
by: Babaei N, et al.
Published: (2025-07-01) -
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience
by: Gioele Ghezzi, et al.
Published: (2024-11-01) -
Aspectos de la IL-17 en la inmunopatogénesis de la psoriasis: un nuevo blanco terapéutico
by: Luis Carlos Ramírez, et al.
Published: (2019-08-01) -
Efficacy of interleukin-17 inhibitors in psoriasis patients: a comparative non-randomized study
by: Arfenya E. Karamova, et al.
Published: (2025-06-01)